MX

MedX

Healthcare Solutions

HomeAboutServicesPublic HealthStrategyRelationshipsContact
Relationship inquirySupply request
MX

MedX

Healthcare Solutions

MedX supports healthcare facilities and public-health programs with pharmaceutical supply, medical devices, diagnostics, cervical-screening program support, and healthcare delivery systems.

Committed to responsible healthcare relationships and reliable service delivery.

Solutions

Pharmaceutical supplyMedical devicesDiagnosticsCervical screening

Company

About MedXLeadership and governanceStrategyRelationshipsPublic HealthContactPrivacyTermsAccessibility

Contact

Bahir Dar, Amhara, Ethiopia

Serving healthcare organizations in Amhara and beyond

Supplier inquiry

© 2026 MedX Healthcare Solutions. All rights reserved.

Supplier inquiriesPrivacyTermsAccessibility

Strategy and Vision

A phased healthcare platform strategy for Ethiopia and regional scale.

MedX’s strategy connects immediate supply and diagnostic needs with digital visibility, local capacity, manufacturing readiness, and regional healthcare access.

Near-term execution
Digital visibility
Regional scale
Conceptual regional healthcare access and medical logistics command center with supply routes and facility readiness dashboards.

Strategic roadmap

Supply • data • regional access

15-Year Strategic Direction

A long-term platform for urgent and future healthcare needs.

MedX’s strategy addresses immediate supply and diagnostic gaps while building future capacity in cancer care, local production, digital systems, research, and regional growth.

Conceptual healthcare supply chain network connecting warehouses, hospitals, and logistics routes.

Conceptual healthcare supply-chain image.

Strategic roadmap

01

Stabilize institutional supply and diagnostic access

Built for phased execution, investment readiness, and public-health impact.

02

Build local manufacturing and import-substitution capacity

Built for phased execution, investment readiness, and public-health impact.

03

Scale digital health visibility and operating discipline

Built for phased execution, investment readiness, and public-health impact.

04

Expand partnerships across Ethiopia and African markets

Built for phased execution, investment readiness, and public-health impact.

Integrated Healthcare Model

Vertical and horizontal integration across the healthcare value chain.

Pharmaceutical manufacturing
Diagnostics
Medical devices
Cancer care
Supply chain services
Social health insurance support
Research and innovation

Technology Partnership Foundation

A historical diagnostics platform linked to Arbor Vita’s global experience.

The 2020 investor presentation positions Arbor Vita Corporation as MedX’s U.S. diagnostics technology partner, bringing proteomic diagnostics experience, intellectual property, and global implementation exposure at that time.

Silicon Valley diagnostics partner
Proteomic diagnostics experience
Footprint referenced in 35+ countries
Manufacturing capability referenced in historical materials
Patent-protected diagnostic technology
Grant and investment-backed development history

Evidence and Partnership References

Diagnostics strategy backed by clinical evidence and institutional collaboration.

The 2020 investor presentation references published OncoE6-related studies and institutional collaboration around cervical-screening technology.

Evidence

Feasibility of E6 oncoprotein testing

Clinical-specimen study referenced for cervical precancer and cancer detection using OncoE6 technology.

Evidence

Lower-cost molecular screening

Evaluation work comparing novel HPV-related screening approaches in rural health settings.

Evidence

Long-term risk prediction

Prospective cohort evidence referenced for E6 oncoprotein risk stratification over long-term follow-up.

Evidence

HPV 16/18 E6 performance

Evidence referenced for detecting HPV16/18-related high-grade lesions in limited-screening contexts.

Local Manufacturing

Import substitution and market reliability.

MedX aims to reduce dependency on imported health products by developing local production and improving availability in critical healthcare categories. Early investor materials referenced a commitment to manufacture 10 million cervical screening tests over five years, demonstrating the scale of the original diagnostics ambition.

Digital Transformation

Better data, faster decisions, stronger transparency.

Smart technologies, automation, data accuracy, real-time decision-making, transparency, and service quality are core to the operating model.

Digital and AI readiness

Responsible analytics for forecasting, screening, and smarter healthcare operations.

MedX can prepare for practical AI by first building reliable data, clear human oversight, public-health value, and measurable service quality across supply, diagnostics, and screening workflows.

Demand forecasting

Use supply, facility, and consumption data to anticipate medicine and device needs before stock pressure becomes visible.

Diagnostic decision support

Support laboratory quality, result triage, referral pathways, and clinical coordination without replacing professional judgment.

Screening program intelligence

Improve cervical-cancer screening follow-up, outreach prioritization, and referral tracking through structured data workflows.

Supply-chain visibility

Detect stock risks, distribution bottlenecks, delayed procurement, and facility-level gaps through operational dashboards.

Responsible AI governance

Advanced analytics must strengthen operational discipline and public trust. Any future AI-assisted workflow should be governed through clear controls, auditable outputs, and accountable clinical and executive review.

Human-in-the-loop review
Data privacy and access control
Clinical and public-health validation
Transparent reporting for partners
Conceptual healthcare researchers in a modern research and innovation environment.

Research and Evidence-Based Innovation

Translate scientific findings into practical healthcare solutions.

MedX can connect research institutions, healthcare programs, and operational delivery to turn evidence into usable products, services, and public health systems.

Strategic Partnerships

Partnerships built for institutional scale.

MedX’s partnership model can align public priorities, facility needs, research capacity, investment, and technology.

Government agencies
Hospitals
Academic institutions
Research institutions
International stakeholders
Investors
Technology partners
Diagnostic technology companies

Financial Sustainability

Diversified revenue protects long-term execution.

The strategy requires revenue sources that support reinvestment, operating resilience, and regional competitiveness.

Pharmaceutical manufacturing
Medical device supply
Diagnostic services
Insurance programs
Research partnerships
Regional expansion

Africa Expansion

Serve Ethiopia, East Africa, and broader African markets.

MedX’s long-term goal is to build a healthcare solutions platform that starts with Ethiopian priorities and expands into regional markets where diagnostics, supply reliability, and local capacity are strategic needs.

Conceptual Ethiopia and Africa healthcare expansion map with connected health facilities.

Work with MedX

Tell us what your facility or healthcare program needs.

MedX can review your request, confirm availability, assess the service requirement, and recommend the right next step.

Submit a requestReview services
Contact MedX
Request callback

Product & supply request

Request pharmaceuticals, medical supplies, devices, equipment, laboratory products, or diagnostic support.

Start request

Facility & program support

Discuss institutional supply, diagnostics, screening, implementation support, or public-health delivery.

Discuss requirements

Relationship inquiry

Explore supplier, technology, distribution, institutional, or implementation collaboration with MedX.

Explore collaboration

Include in your request

Organization and location

Products or service needed

Quantity and urgency

Preferred delivery timeline